In high school. I heard the rumors and saw the writings on bathroom walls of the quote dirty people who slept around and got STIs like the clap. I never wanted to be like them, and I thought I was better than them for being quote cleaner and selective about whom I was seeing. I thought I was doing everything right, So you can imagine my surprise when my senior year of high school, my then partner and I tested positive for chlamythia. I was shocked and confused, wondering how it
had happened. I felt ashamed and dirty, angry both at myself and my partner. Thoughts like I'll never have sex again and my life is over flashed through my head. I even blamed the person my ex contracted it from. I felt betrayed by my partner, thinking how could you do this to me? But after a conversation with my doctor, who was very familiar with these cases, my assumptions about the disease were thrown out the window and replaced with a new understanding. A simple round of antibiotics and we'd
both be fine. I felt the stigma had dropped, and I wasn't shy to tell my story to let others in the same boat know that it isn't the end of the world, and that you are not defined by a diagnosis. I was proud to handle it the way I did. Then college came, and it followed me. I hooked up with a person who turned cold towards me. Days later, I knew something was off, and I asked them about it. They told me they heard about my past. They said that they had heard quote something about chlamydia
and it scared them. They were ashamed for being intimate with me as someone who was once diagnosed with this infection. They thought I was dirty and that it made them dirty too. The feeling of rejection cut deep, and I begged him to keep his voice down. Doing what I could, I told him some of the facts. I knew how men are usually asymptomatic, how antibiotics are used to treat it, condoms are one method of prevention, and how it can
increase the risk of pelvic inflammatory disease in women. Still, I was so angry and shocked that this had happened. Of course they didn't know better, but maybe they should have. I was upset both for the judgments they made about me, but also anyone who had been diagnosed with an STI. I thought to myself, why am I to blame? Why not my male partners? Why not the disease itself? What
blame is there to be had? Anyway? I have learned my lesson that what matters in sexual intimacy is not rumors and history, but who someone is at their core, and whether or not their values and understanding of the world aligns with yours. What's important is mutual respect and open and healthy communication. STIs can happen to you virtually anyone, and your value as a person has nothing to do
with your sexual health. You are not a diagnosis. I feel like that is just such an important message, right like you are not a die diagnosis.
You are not your diagnosis. It's my favorite. I had a whole pairagraph at the beginning of my notes that's all about why it's so important that we talk about chlamydia, because it is so common and we need to reduce the stigma. So I love that first hand account.
Thank you. Yeah. So that story was sent in by one of our listeners, and I, yeah, I just want to say a huge thank you to both this listener and also to everyone who has ever submitted a first hand account because it is a really vulnerable position to be in, right, Like you're kind of bearing your soul talking about your experiences something very personal to you, and
that's difficult to do. And I just want to acknowledge that and say thank you, and also that it's so wonderful and impactful, because I feel like it really drives home that like, these diseases do happen, These things happen to people who are living their everyday lives. And yeah, I think it just sort of reinforces once again, you are not a diagnosis. Yeah. Yeah, Hi, I'm Erin Welsh and I'm Erin on an updike and this is this podcast will Kill You.
Welcome to Chlamydia.
Welcome. Yeah, this is an interesting one because it's sort of like a two for the price of one episode.
I would call it even two point five, as you'll hear in the biology.
Yeah, I'm very intrigued by that. So is it a certain time of evening the time it's quarantine time?
According to I'm actually wearing a watch today.
You are what are we drinking this week?
Erin, We're drinking Happy as a clam get it clamydia?
Yeah, c h L A M. Yeah, and in a happy as a clam is of course clamato. How could we resist at tequila? And basically it's your standard bloody mary, but with tequila instead of vodka. And yes, we do know that we made a bloody mary for typhoid, but it's with clamado, so it's with coronato and it's with tequila instead of vodka. So hopefully that's different enough.
And in any case, we'll post the full recipe for the quarantine and the non alcoholic clamado based plus e verrita on our website, This podcast would Kill You dot Com and all of our social media channels.
On our website, you can find all sorts of things like transcripts, sources for all of our episodes. You can find links to music by Bloodmobile. You can find links to our bookshop dot org affiliate account. You can find links to merch and Patreon. Probably a few more things that I'm forgetting, but you know that's enough.
Check it out, check it there.
And just real quick, I wanted to mention again that if you have a first hand account that you might be willing to share on the podcast, please shoot us a message on the contact us form on our website or send us an email at this podcast will Kill You dot com. I'm also putting it on my to do list to create like an FAQ or like a first hand account link, so that maybe things will be set up more easily on the website and you can get more information.
Oh well, then shall we dive into this episode.
Let's do it right after this shortbreak.
Is that how you would say that chlamydia chlamydia with an E at the end?
Yeah?
Sure, Chlamydia are gram negative obligately intracellular bacteria, of which there are several different species, and they infect a pretty wide range of hosts and within those hosts a wide range of body sites. So we'll talk in this episode about different tissue tropisms, which we've talked about before, but that essentially just means which cell types these intracellular bacteria like to infect. There are two major species of chlamydia
that infect humans. Primarily, that is Chlamydia pneumonia, which causes pneumonia so it infects our respiratory tract, and Chlamydia trachomitis, which is really the subject of today's episode. But other species can cause respiratory or eurogenital or chloacal or conjunctival infections in mice, birds, cats, pigs, marsupial snakes, turtles, guinea pigs, koalas, and probably other animals that I didn't mention, and some of these other species just as like a fun side note.
For example, Chlamydia citassi, if I'm saying that right, is often a zoonotic pathogen that can cause disease in humans. It causes a disease called cydycosis, but it's primarily a bacteria of I believe birds. Anyways, all of that to say that today we're focusing on one species of chlamydia, and that is Chlymydia trachomitis. This is a human specific bacterium. But there are at least thirteen, maybe nineteen different erra VARs, and these seri VARs cause different diseases kind of a
number of them. Let's get into it. Err of rs A, B, and C cause an infection of the eyes that's called trachoma, which can lead to scarring and blindness and is a really important major cause of blindness in many parts of the world. Cerr of rs D through K cause what most of our listeners are probably familiar with as chlamydia, the sexually transmitted infection, and then the L SERR of rs, of which there are several cause another sexually transmitted infection
called Lymphogranuloma veneerum. Oh, so it's like three different seer of R groups that cause three different types of diseases. More or less there's some nuance there. So what I'm going to do here is take a pretty big picture view and talk about what all Chlamydia trachomatis has in common, and then will go over the kind of different presentations
of those diseases. Because it turns out, even though each ser of R like infects different tissues and maybe causes slightly different diseases, there's a lot of similarities in terms of the basic biology of how this pathogen works.
That's so interesting that there are like distinct seri of VARs. Yeah, the differences among these SERR VARs Are they genetic? Is it just how they act? Is it expression?
Like?
What is the origin of those differences? Yeah?
Oh, it's a good question, Aaron. I wish I had a good answer for you. Oh I don't. And that's not to say that it might be that a good answer exists out there better than what I can explain it. But what it really comes down to at a very basic level is differences in tropism. So the different serr of vrs have a tendency to infect different tissue types,
and that probably is based on some specifics of their genetics. Okay, but as we'll see, especially the classically sexually transmitted zero vrs D through K actually have a fairly wide tropism. So it's also differences in just the kind of epidemiology of where you find them and who tends to be infected and things like that.
Fascinating. I want to know so much more about tishoot tropism, So let's get start happy.
Wouldn't that be fun? So Chlamydia, like I said, it's an obligate intracellular bacterium, so it can't replicate without entering a host cell. Chlamydia bacteria are kind of fun. They have two different parts to their life stage. One is a kind of sporelike infectious form called an elementary body, and that's what actually infects our cells. And once these bacteria actually enter our cells, they actually differentiate into an
active form that replicates prolifically. And then we'll transition back into the infectious elementary body to leave our cells and go on and infect more cells.
Interesting and yeah, so you mentioned that this was a spore like condition. What does that mean exactly?
It means that they are hardy, and they are not extremely metabolically active. They're not completely inactive, but they don't replicate and they're not very active, and they're a little bit hardier than most bacteria.
How hardy are we talking? What's the environmental durability of it?
I didn't see how long the environmental durability is. It's not like a true spore. It's not like drying and surviving on surfaces. It's not anthrax. No, no, good question. So chlamydia, all of the different sera VARs of Chlmydia trichomitis is transmitted generally by direct contact with secretions. And what secretions depend on what tissue we're talking about, but in general, Chlamydia trichomitis has the ability to infect any of our mucous membranes. So anywhere that you have wet,
vulnerable epithelial cells, you could get infected. That means eyes, nose, throat, penis, vagina anus primarily, and associated structures and like I kind of touched on a lot. The different err of rs have different tissue tropisms. So cerr vrs A, B, and C tend to like the epithelial cells of our eyes and our nose. That's their preferred tissue tropism. That's where they do the best d through K most often infect our genital tract, but can also absolutely cause infection in
eyes or throat. And then the l zer of rs, the ones that I think we think of the least often. They also tend to be sexually transmitted, so primarily infect the anogenital region. But what's really different about the l serra rs is they have a tendency to invade past just that epithelial cell layer and cause a much deeper infection, which I think is fascinating and really does set them apart from the other seer.
Of rs interesting. And so the deeper tissues that it invades, what are those deeper tissues made of?
Oh, great question. It tends to invade into the lymph nodes. And we'll talk a little bit more about that when I talk specifically about lymphogranuloma veneerum. I know I can see.
Your face, yeah, okay.
But despite those differences at pretty much all of the sites of infection. One thing that chlamydia does across all serr of rs is it induces a pretty intense inflammatory
reaction from us. And so what we'll see when we talk about the different symptoms is that while those symptoms are going to vary, of course depend on what tissues infected, depending on which mucous membrane is exposed, the inflammatory reaction itself is universal, and as we talked about in our endometriosis episode, that inflammatory reaction that our body generates can often result in scarring, and this scarring can have chronic
or long term consequences. And that's across the board regardless of tissue type. So when we talk about chlamydia, there's always the acute initial infection, but then there's also the potential for this inflammation to cause scarring that can cause more permanent or progressive damage.
I find that really intriguing because, as I'll briefly touch on, these microbes have been evolving with humans for ever forever, So it seems like that would be that it would be selected for to have not so much of an inflammatory response or not cause so much inflammation either from the human side or the bacterial side.
Well, what's interesting is that, yes, this is a pathogen that's been with us for a very long time. This is a pathogen that actually has a really intimate relationship with our cells and with our immune response. So what it actually tends to do is block a lot of pro apoctotic So it blocks a lot of processes that just straight up kill infected cells, because that's what our body usually does when it recognizes an infected cell, is
just kill it. And instead, what chlamydia tends to do is modulate progression through the cell cycle in a way to try and promote chlamydia's own growth and survival for as long as possible. So I suspect that the inflammatory response is more of a like a last ditch, like, let's do what we can. So it's this constant battle between this bacteria that's inside of our cells and our body trying as best it can to fight it off, but then causing damage in the process.
Gotcha, Yeah, do our bodies clear chlamydia infection on their own?
Excellent question? They absolutely can, yes.
Okay, And so does the inflammatory response then vary substantially from person to person, And like the tendency to scar and stuff like that. Probably, yeah, okay, what factors might contribute to that?
Oh, Aaron, whenever we ask about host factors, my answer.
Is great question, fair, we gotta have.
Angie Rasmussen back on to I heard. No, that's a really good question though, But yes, it presumably definitely would very person to person. What those factors may be is probably the subject of an intense amount of research.
All right.
So that was chlmydia in general. So now let's kind of go through the different sea of rs and sites of infection to understand what these diseases actually look like. So cerra vrs, A, B, and C cause trachoma. A lot of listeners may have never heard of trachoma, even though it is one of the most common causes of infectious blindness worldwide. But these serr rs are generally transmitted from person to person by direct contact from eye and
nose secretions. So think rub your eye on your hand and then touch somebody else, or you know, you're nuzzling with your baby, snuggling with your kid and you get their goopy eyes and nose all over you, or you're sharing a towel. It can also be transmitted by I seeking flies. Although the relative importance of I seeking flies and all of these various modes of transmission, it's a little bit like we don't know which is the most important.
But anyways, as an acute infection, an initial infection these err rs are of Chlamydia trachomatis cause a mucopurulent conjunctivitis, so an infection of the eye and the conjunctiva, and it generally is self limited, like you asked aaron, it usually resolves. However, reinfection, especially in children, is incredibly common
in endemic areas, and so trichoma. The disease that results is the result of either longitudinal, continued active infection, which can also occur if you don't completely clear it, or chronic inflammation that results because of repeated infection, and this inflammation can actually persist even after infection is resolved. And in either case, whether it's a you know, continual infection or continual reinfection with inflammation, it results in significant scarring
to the eye and to the cornea. So it tends to be young children who are infected frequently and recurrently, but this scarring takes place over the course of decades, and what really happens is that the scarring it causes the upper eyelid to kind of turn inward, which then eventually progresses to something called trichiasis, which is when the eyelashes in turn and begin rubbing against the eye like sorry, I know, eyes are difficult.
Eyes are difficult. It is that. Yeah, I saw a lot of pictures and descriptions in the books that I read, and it it sounds so like painful and so painful, horrifically uncomfortable. That is, yes, it's yeah, yeah.
Exactly like you. I think we've all had the sensation of having an eyelash stuck in your eye, right, imagine it, all of them, all of them, and always like you. It's not like you can just take it out. It's it's the way that your eyelid has turned. And so this, in addition to being incredibly incredibly uncomfortable, this constant rubbing actually leads to additional scarring of the cornea and this
is what leads to blindness, gotcha. And so the prevalence of scarring and blindness in adults relates to their exposure as children, which is kind of an important like public health concept because it's an acute infection that then causes this chronic disease in chronic scarring.
Right, it helps with who to target to disrupt this cycle of transmission, chain of transmission yet exactly.
And it really has to be a kind of multi tiered approach because you have to both, you know, prevent the disease in children and treat the disease in children, but then you also have to be able to deal with the after effects of the chronic infection in adults. So that's trichoma. Next to go into the chlamydia that everyone is probably more familiar with, and that is servrs D through K sexually transmitted chlamydia. So these are the
SERI VARs that tend to cause anogenital infections. So in people with a penis, chlamydia loves to infect the cells that line the urethra. Inflammation in this area is going to cause a urethritis, inflammation of the urethra. Often it's called non gonococcal urethritis, which I think is just so silly because it just means like, well, it's not gonorrhea.
I have a little section about that, so I can't wait. You'll understand where it came from and why why people start using it in the first place.
I can't in people with a penis that this urethritis can also be complicated by epididymitis, which is inflammation of the epididymis, which is where sperm are stored and transported in the testicles. And one thing that's really important to know is that even in this population, when it's a penile infection, thirty to fifty percent of the time it's completely asymptomatic. So someone is not going to know that they're infected and potentially infectious.
Right.
If someone is going to become symptomatic, then the symptoms usually are like a pain or burning when you pee because of that inflammation, or maybe a little bit of clear or white discharge. In people with a CERFX, seventy to ninety percent of the time infection is entirely asymptomatic.
It's so interesting that it's a different rate of asymptomatic, Like why is that?
Well, I think it's largely because the symptoms that you're having from a urethritis are the pain and burning with urination because you have urine passing over these inflamed cells. But with a serviceitis, which is inflammation of the cervix, which is the most common place that you're going to
have infection in someone with a CERFX. In a sexually transmitted chlamydia infection, the cervix is pretty high up in the vagina, and so even if you do have that mucopurulent discharge, which is what you may have, you might
not notice. It might not be painful, you might not have any other symptoms, and so you can have things like a little bit of bleeding after intercourse or if you did like a speculum exam, you might see the cervix look a little bit swollen or have a little bit of bleeding if you did a swab, but you might not feel that necessarily or notice it in terms of symptoms. That makes sense.
That makes sense. Yeah.
Interesting, Now if a person with a cervix can also have a urethritis, right, because the urethra is really really close to the vaginal opening, and that might be more likely to be symptomatic. But you might think it's a UTI or a bladder infection, right because the symptoms are going to be similar.
What about the anus.
The anus absolutely can be infected and it may or may not be symptomatic. We'll talk more about the anus in a little bit. Don't worry, I won't leave out the anus.
Perfect good. I'm relieved.
Now I want to focus on the cervix for a little bit longer because one of the things that makes chlamydia infection especially dangerous considering how often it's asymptomatic, is that with a cervical infection, if it's untreated about twenty to forty percent of the time, that infection can progress upwards through the endometrio canal. Because this is a bacteria that's spreading from cell to cell, it can spread through the uterus and up into the cells that line the
Phillipian tubes. So it can cause an endometritis, which is inflammation of the endometrium the cells that line the uterus, or a salpingitis, which is inflammation of those Filipian tubes. And if an infection ascends into the uterus and the Philippian tubes, that can become a persistent infection known as
pelvic inflammatory disease. And that inflammation, just like it can happen in the eyes with the trichoma serre of ours, can cause a lot of scarring over time, and this scarring is a big risk factor for both infertility as well as ectopic pregnancy, which can be a life threatening emergency.
So I have a few questions. Number one, can you talk a little bit more about pelvic inflammatory disease? What that is?
Yeah, Pelvic inflammatory disease is when a bacterial infection spreads up into the uterus and the Filippian tubes. So it's very often caused by chlamydia, but it can also be caused by gonorrhea, which I think we talked about in our gonerhea episode. Or it can be caused by a number of other bacteria, just bacteria generally bacteria.
Yeah, okay, okay. And then another question is about ectopic pregnancy. Why is that? Why is that associated with chlamydia infection? That has ascended great.
Question because that inflammation can cause scarring in the Filippian tubes such that even though sperm might be able to make it through the Filippian tube to fertilize the egg, the egg can't make it back through the Filippian tube to be able to implant, or all the way through the Philippian tube to be able to implant safely in the uterus, So it implants ectopically, which just means outside of the uterus.
Okay, Yeah, So in terms of infertility, what is the process by which this inflammation from chlamydia causes infertility. Is it sort of certain steps or is it multiple steps or is it just like the general inflammation.
Yeah, it's so the general inflammation and the scarring that occurs because of that inflammation.
Gotcha.
It's not like something that happens overnight or over the course of even you know, a few days. This is the result of a long standing, untreated infection or repeated infection that's untreated in general, similar to trachoma in.
That way, right right.
Chlamydia can also lead to infection in a newborn during delivery. Most commonly affects the eyes and causes a conjunctivitis or can descend the respiratory tract and cause a pneumonia. So this is really a very versatile bacteria.
So the one that can cause a pneumonia in newborns is not chlamydia pneumonia, but chlamydia.
I mean, chlamydia pneumonia could also cause pneumonia tiborns, but normally, yeah, Chlamydia trichomatis. If someone is infected during delivery and delivers vaginally, then the baby could become colonized and therefore chlamydia trichomtis pneumonia.
Wow okay, yeah, yeah, very versatile really is.
Now the L serra VARs we haven't even touched on, so I'll breeze through it really quickly. But these are the ones that cause lymphogranuloma veneerum. This is a disease that tends to be more deeply invasive than the other seri VARs. So they establish an infection not just in the epithelial cells of say the cervix or the urethra or the anus, but they infect cells deeper in our submucosa and then are able to disseminate through our lymphatics
to our lymph nodes and cause a more systemic infection. Now, what's interesting about this especially is that it used to be considered a relatively rare disease in high income countries and classically was described as like a painless ulcer followed by lymph node swelling, et cetera. But over the last few decades has become a much more common pathogen that more predominantly affects the anogenital region and can cause significant
inflammation in the rectum. In people that are having receptive anal sex.
Interesting.
Yeah, And of course the other SERI VARs of chlamydiatrochomitis can also infect the anal region, but this specific zero type seems to really like the anal region and can cause a more disseminated infection. So it can cause things like recto bleeding, pain, a mucoid discharge. It can cause something called tinismus, which is this horrible sensation that you have to have a bowel movement even when your rectum is empty. So it can cause a lot of muscle
spasm and be really painful. So the symptoms can actually be confused with inflammatory bowel disease because these symptoms really overlap. Huh h.
And is this just because it has a tendency to invade more deeply and so like the infection itself is just more exactly intense and almost systemic kind.
It is, and it is it's harder to treat. It needs a longer course of antibiotics.
Okay, exactly, Yeah.
I swear I'm almost done. But there's like one more thing I can't not talk about, and that is that chlamyty infection can also cause what's known as a reactive arthritis, oh, which happens weeks later after an infection, and it can cause arthritis, so pain in the joints and inflammation in the fluid in your joints, and also a conjunctivitis, which is fascinating, Like, how did the inflammation make it all the way up to your eye after just a urethral infection.
I don't know the answer to that. We don't know the answer to that. It's really unclear if this reactive arthritis is caused by a persistent chlamidial infection or if it's caused by just our immune response causing this inflammation that that becomes more widespread. Chlamydia is not the only cause of reactive arthritis. Salmonella, Camplobacter your senia, a lot
of other bacteria are also associated with reactive arthritis. But one of the pepers that I read said that up to four percent of people with an acute Chlamydia trichomitis infection go on to develop reactive arthritis, which is way higher than I thought.
Yeah, okay, questions. This is for all serovars of Chlymydia trichomtis.
I think it's mostly d through K but I don't think that it's impossible that any of the serra VARs could potentially cause.
This, Okay, And would this happen even if you go on a course of antibiotics and clear the infection that.
Way, great question. I think yes, potentially.
Okay, So this is like the chlamydia trichomitis is no longer there, but your body is still reacting to something.
Well, yes, but the bacteria are often able to be recovered from synovial fluid in people with reactive arthritis, but it's unclear whether they are active infectious bacteria or not. Remember, there are multiple stages of the life cycle of chlamydia, and whether or not antibiotics are effective in treatment is
really up for debate right now. So it's unclear. It's one of these areas that, much like so many you know, chronic and autoimmune inflammatory conditions, again, is ripe for research because we just don't really understand this reaction.
How long does it last?
I think it tends to resolve even without treatment, within at least a few months.
Okay, Yeah, fascinating.
It is really interesting. And I mean that's chlmydia trichomitis in not quite a nutshell but like maybe several like puts, yeah, a back of peanuts, or like boiled.
Peanuts where you have like five sometimes in a shell.
Yeah, you know, I don't eat hot boiled peanuts.
That's true. That's true.
I mean I've eating peanuts.
Hot boil peanuts are the best though. Yeah.
Well, anyways, it is still a treatable infection. All of the different serra VARs are treatable, which is great, and it's all with the same antibiotics, either doxy cycling or as a thermycin of course longer for the more deeper infection. Like I mentioned, antibiotic resistance, it's a thing. It's a thing, and that is part of why it used to be that in the US, sexually transmitted lamydia was treated with
one time dose of az atherrmycin. But now there's more data that shows that actually curates are better with doxycycling, even though it's a longer course it's seven days. So yeah, antibiotic resistance is definitely a thing. I think it's not yet as severe as say, with gonorrhea, but let's hope we don't get there.
Yeah, I was gonna say, just wait, just wait.
So yeah, any other questions I don't know if I answered any of your questions adequately.
You did, No, I feel like I feel like I'm all set for now, but I'm gonna keep thinking in the back of my head as I tell you the history.
Can you please I want to know all about it.
Yeah, I'll take a quick break and then I'll get into it. Just like with the biology section, I feel like we can split the history of chlamydia trachomitis into multiple parts as well, but in this case, I'm going to do it in two parts based on its name. So there's what we can think of as the chlamydia part of the story, So that's what I'm calling the disease as an STI, like the pathogen as an STI.
And then there's the trachomatis or trachoma part of the story, So the bacteria as the cause of this ie infection, the severe chronic eye infection. Yeah, and that's kind of how I decided to approach this history, except for the fact that I am going to be giving trachoma more airtime than chlamydia as an STI, partly because and I was a bit surprised to find this that trachoma has a much deeper and a much more extensive history than Chlmytia as an STI, because that was really only recognized
as an STI fairly recently. Really yeah, which, of course it doesn't mean that it only emerged as an STI recently, but in terms of like clinical recognition, yes, huh yeah, so kind of like you did. I'm gonna start with the evolutionary history overall, and then I'm going to go into tracoma and then talk a bit at the end about chlamydia. So I'm going to call this the trachomitus
chlamydia approach. I love it, thank you. For quite a while, people thought that chlamydia were mainly mammalian pathogens, infecting mammals and a few other animals intracellularly. But then in the late nineteen nineties, some researchers observed chlamydia acting as endosymbions inside free living amibe. They're not in the same genus like, for instance, one is called parachlamydia, but they are related
to these intracellular pathogens. Okay, okay, yeah, And this showed that not only are chlamydia way more diverse than people previously thought, but also much older, like seven hundred million years old. Oh that's yeah, But we're not going to
go through all seven hundred million years of history. Let's kind of get to where the human chlamydia specific strains or species that were interested in, right, So chlamydia trichomitis, essentially the strains of chlamydia that cause eye infections apparently diverged from the strains that caused genital infections around two million to five million years ago, which is around the
time that Homo habilis and Homo erectus evolved. So these guys have been with us for you know, like we said, as long as we've been human, yeah, forever, And ancient writings further confirmed that. So now is where I switched to focus on tricoma. Okay, So, even though tracoma has probably always impacted humans, the transition to larger settlements and decreased mobility would have provided more opportunities for the infection to spread to more people, both within communities and also
along trade routes. And its widespread prevalence is it's evident in the fact that trachoma is described in so many ancient texts, like so many really, Yeah, let's go through a few of these early mentions, starting with the more vague mentions and then getting more specific. There's a description from sometime during twenty six hundred to twenty seven hundred BCE about an emperor in China undergoing surgery for trachiasis.
And there are inscriptions of eye disorders found on animal bones and tortoise shells from around eleven hundred to sixteen hundred BCE. And there are also bronze age appellation forceps used for removing eyelashes found in Sumeria from around twenty six hundred BCE.
Wow.
Yeah. The first specific references to trachoma come from around four hundred and twenty to five hundred and eighty one BCE in China, and in these references, trachoma is described with terms including quote pepper seed like lesions and quote milk like granules and copper. Octopus and garlic rubbed on
the eyelids was a commonly recommended treatment. Then we have writings from Sushruda from the seven hundreds BCE, who is an ancient Indian physician and surgeon that I've mentioned on the podcast at least a few times, like I think many times. Specifically, actually look this up in our diabetes, rabies, and organ transplantation episodes.
For example, that you looked it up.
I did, I did so. Sushrudo wrote about how the inner eyelid gets rough and thick, and how the eyelashes can grow inward, and how your eyelid can also turn inwards and cause slashes to rub against your eye. It's like pretty like spot on tracot right, the early history of tracoma. Honestly, it reads like who's who of the early medical texts, because up next is our old friend, the ebers Papyrus.
I was hoping you'd say that.
Of course I was going to say that. So into this classic text, which is from around the fifteen fifties BCE or so, we've got lots and lots of different treatments for eye disorders, including onions, gazelle excrement applied to the eye with a vulture feather oh wow, and appellation,
followed by the application of lizard or bat blood okay. Interestingly, both Plato and Aristotle suggested that tracoma was contagious, with Aristotle going so far as to suggest that you could get it just by looking at someone who had it. Oh yes, but it would take it quite a long time, of course, before they were vindicated in this belief. And we have another friend yet who is joining us, which
is Hippocrates and the Hippocratic texts. Yep. And in these texts there are descriptions of the fig like appearance of the upper lid and intern lashes, and also some suggestions that the condition could be prevented by avoiding the cold winds from the north and the warm winds from the south, which like, what winds are you left with?
But just avoid all winds, avoid all winds. You can have an easterly breeze. That would be fine, Okay.
Yeah, yeah. But also I really love these treatments. Drinking wine, bathing yep, I'm down for that, purging nope, blood letting nope, or applying a cleansing medication to the affected area.
Okay, yeah, we've got some decent ones in there.
Yeah.
And of course there were also surgical procedures that were recommended to treat tricoma in these texts. In the first century CE, the ancient Greek physician Diascorides was the first to use the word trachoma, meaning roughness, to describe the condition, and a little over one hundred years later, Galen described
the four stages of trachoma. I mean I could, honestly, I could go on and on this entire episode, just like listing these other ancient texts that have references to tracoma, like those by Avicenna and Alcohol the Ophthalmologist, among others. And also like you know that I would love to get into some of these, you know, these incredibly varied treatments used egg, white mouse, ear, frog's blood, the bile
of a goat, et cetera. But even without doing that, even without going further down this like rabbit hole of like ancient texts and tracoma, I feel like it has given us a pretty good sense of how widespread and devastating a problem this was.
Yeah, I honestly had no idea. I mean, it makes sense even now, like looking at the distribution and how many people are still at risk and affected, like it makes sense. But I never realized.
That, yeah, me either at all. I really thought before researching this episode, this is going to be an STI history where I'm going to talk about like when people realized chlamydia was different than gonnerhea et cetera, et cetera. And then I realized like this is really fascinating and important, and it just gets more so because if you thought it was widespread in the ancient world, of course, it's only going to get more widespread as global population increase,
mobility increase, and so on. Yeah, so I'm going to mention one more thing and kind of like olden times before jumping all the way ahead to the eighteen hundreds. Okay, So, during the Crusades in like eleven hundred to twelve hundred CE, a ton of crusaders and pilgrims that were venturing to the Holy Lands, and many of them came back with tracoma, one of them possibly being Saint Francis of Assisi, who was actually blind at his death in twelve twenty six.
I'm loving this.
All right, So now let's get to the eighteen hundreds. And why the eighteen hundreds, you might ask. So from the ancient times to then, of course, tracoma was around, It was written about, it was described, it made an impact. But also it was kind of used sometimes as a catch all term as this umbrella term to describe both the acute phase and the chronic phase. More eye infections caused by other pathogens it was not really featured as
sporadically or studied very intensively. But all of that would change around the early eighteen hundreds, and the reason for that change is, of course, war, specifically the Napoleonic Wars. Poor Napoleon has been featured on this podcast for way like so many times, for all of the disastrous campaigns where he was just basically his army was wiped out by various diseases. Right all the way back in season one,
we're talked about him in yellow Fever. In our Typhus episode, we talked about how an unbelievably huge number of his soldiers died from Typhus while trying to march up to Russia. But with Trachoma and Napoleon, we find ourselves not in Russia or Hispaniola, but rather in Egypt. From seventeen ninety eight to eighteen fifteen, Napoleon decided to wage a series of campaigns basically all over the place to try to gain more control over the European continent, largely by disrupting
British colonial and Econo rule. That was his aim. In July seventeen ninety eight, Napoleon landed near Alexandria Egypt, and then he and around forty thousand French troops marched to Cairo. And the purpose of the Egypt invasion, from what I can tell, was essentially to establish a foothold in the region so that they could try to disrupt one of the main sources of British economic power, India, by driving
the British out of that subcontinent. So they were like, all right, we're going to set up shop in Egypt and then from here we're going to just get like we're going to defeat the British. Okay, it also came with the plus of establishing French trade in the region. Not long after they arrived in Egypt, however, Napoleon's troops began to experience many of the illnesses you'd expect a traveling army to dysentery, excessive dehydration, and also eye infections.
By late September, the prevalence of eye infections or inflammation had grown enormously. For example, in one battalion of three hundred soldiers, one hundred and twenty five had ie inflammation severe enough that they were effectively blind wow and had to rely on their unaffected comrades to point their guns in the right direction from the trenches.
Oh dear, mm hmm.
And the high prevalence in this battalion doesn't really seem like a one off, because in an expedition in October seventeen ninety eight, fourteen hundred French soldiers developed ophthalmia out of three thousand, so nearly half wow. And the condition was not restricted to just the French soldiers fighting, but also the people they were fighting against, namely Turkish and British troops, although Turkish troops later switched sides and fought
against the British. So everyone was affected essentially, is what I'm trying to say. And the British army seemed especially affected by eye inflammation after around March of eighteen oh one. One report from the time described how out of an eight thousand person division, sixteen hundred soldiers developed ophthalmia in September and October, and one hundred and fifty eight became blind just like a lot. That's a lot of people.
Napoleon's invasion of Egypt marked a turning point in the history of tracoma because it led to huge amount of interest in the disease, especially from military physicians, and it also led to the infection spreading much more widely. When these British and French troops returned to Europe from Egypt, many of them brought tracoma back with them, and basically
everywhere they traveled on their journey home, tracoma followed. For instance, French troops landing in Sicily in eighteen oh one on their way back from Egypt kicked off an epidemic of trachoma that didn't peak until twelve years later. Just rose and rose and rose. Yeah, oh my gosh. This time of the Napoleonic Wars and really in the years after was a period of great upheaval and mobility across huge parts of Europe, and trachoma was, you know, was not
alone in this. It was just one of the diseases that took advantage of this disruption and widespread travel. Tracoma moved from Sicily to Hungary, France, the Netherlands, Germany, Russia and on and on and on essentially everywhere, and it especially became a fixture in armies. Ophthalmia first showed up in the Russian army in eighteen eighteen, and within twenty years nearly eighty thousand Russian soldiers had been affected. Thousands of soldiers in the Dutch and Belgian armies became blind
or partially blind. And during the Crimean War, so like eighteen sixty one to eighteen sixty seven or so quote, four percent of all disability in the army was due to ophthalmia and five percent of the total discharges were because of blindness, although these rates were approximately half what they had been in the eighteen thirties. Wow yeah, So ten percent of the discharges being due to blindness in
the army, Wow yeah. And so you know, doctors, military doctors and also civilian doctors had plenty on their hands in terms of trachoma, And as you might expect, one of the things in the front of everyone's mind was how to control or prevent this disease, which, in the years before germ theory was tangled up with a debate
on whether tracoma was contagious or not. Was it warm rains or cool nights, was it a dusty atmosphere or a cold wind that led to outbreaks, or was it the sharing of hand basins, not washing regularly, sharing towels, not cleaning bedding, or not using pillowcases, etc. And in reality, it was kind of a little bit of both, because you know, having access to clean your face or not sharing towels one big part of it, and some environmental
factors playing another part through seasonal changes in fly prevalence, for instance. While some doctors continued to work on the control aspects of trachoma, others began to concentrate and specialize on how to treat the condition. The author of the book that I read for this compared tracoma to Helen of Troy, but rather than ships, tracoma was the disease that launched a thousand hospitals. I loved that by the mid to late eighteen hundreds, tracoma was a pervasive problem
everywhere and it wasn't limited to just the military. Entire hospitals and medical visions were created to treat it. And trachoma also played a big role in making ophthalmology a specialization and profession in itself, rather than it being just a part of generalist care. Like generalists who have an interest in ophthalmology.
Wow, that's I had no idea.
I know, the history of trachoma is so much deeper than I realized, and it's also just I really find it interesting to think about the origins of different specialties and specializations in medicine.
Oh my gosh, I know.
Yeah. Governments established tracoma schools attended by children who had tricoma or other eye conditions because, like you said, it was so prevalent among children, and it also became a notifiable disease in many places. By the second half of the eighteen hundreds, researchers had fully established that trachoma was indeed contagious, even if they wouldn't discover the causative agent
until in nineteen oh seven. But knowing that trachoma was caused by an intracellular bacterium didn't stop people from characterizing the epidemiology of the disease. Familial transmission was common, children under seven had the highest prevalence, seemed to be strongly correlated with access to sanitation and clean water, and it
seemed to be most prevalent among low income households. And of course these last two characteristics, so low income households plus lack of access to sanitation or hygiene practices, these marked the disease as a social status indicator, similar to many other diseases that we've talked about on the podcast before, tuberculosis, hookworm, trachoma. These were the diseases that the poor brought upon themselves
just by being poor. That was like the narrative, right, These diagnoses became wrapped up in a person's identity, labeling them unclean.
I feel like that's still the problem with tracoma and why we don't know anything about it.
Absolutely. Absolutely. Although some control strategies for tracoma involved providing care to people who had the disease, many of them focused more on limiting the spread of the disease to wealthier populations. Right. It wasn't so much let's manage and stop the cycle of transmission. It was like, let's keep the cycle of transmission over there and not let it spill into here.
Yeah, which is not only cruel, it's also ineffective.
It truly, truly is. So. It seems unclear whether or not tracoma had been present in the US prior to the arrival of Europeans in the fourteen hundreds and fifteen hundreds, but in any case, the late eighteen hundreds saw a similar increase in tracoma in the US that the rest of the world was experiencing, and this rise in cases
was blamed on immigration. Throughout this time and into the early nineteen hundreds, millions of people were leaving their homeland, which was often somewhere in Europe, to travel to the US and try to find more opportunities, or be with their family, or escape some of the horrible situations that
were happening, like famine, many many, many different reasons. And I'm not going to go in depth about the immigration politics of this time because I don't know enough about it and there's probably better podcasts and resources out there, but I will say that as immigration increased in the late decades of the eighteen hundreds, so did resentment and anti immigration sentiments, which eventually led to policies aimed at reducing immigration by especially targeting people that they didn't want
to admit into the country, for instance the Chinese Exclusion Act of eighteen eighty two, or other laws or acts that prevented people from being admitted if they had certain disease, including but not limited to, epilepsy, quote insanity, tuberculosis, cholera, typhus, ringworm, and trichoma. In eighteen ninety seven, the US Surgeon General called trachoma quote a dangerous contagious disease, and instructed medical
officers to examine all immigrants. The examination process itself was painful and not at all sanitary, which probably led to further spread of trachoma. You're like, let me check your eyes. Okay, next, let me check your eyes. Oh you have tracoma. Oh let me check the next person's eyes.
Yeah.
If you were suspected to have trachoma, the officer would mark a big chalk tea on your shirt and you were sent to the contagious disease hospital to wait it out to see whether you had acute conjunctivitis or if it was tricoma. And if it was tracoma, that was bad news. Over ninety five percent of those with tracoma were deported. Whoam. And if you were fortunate enough to be in the five percent not deported, you could remain in the US in hospital for treatment, but that usually
took about six months. Whoa huh, because remember this is all pre any sort of effective right antibiotics? Antibiotics. Yeah. In nineteen oh two, the US ramped up their restrictions against tracoma by placing a one hundred dollars fine on every shipping company per tracoma case brought to the US. So then these companies started to do like port of origin screening sites, and these additional restrictions led to tracoma becoming one of the main reasons that prospective immigrants were rejected.
Let me read you some numbers to give you a sense of just how much tracoma played a role in immigration. Quote, between eighteen ninety seven and nineteen twenty four, some twenty one million, seven hundred and fifty eight thousand, eight hundred and seventy five immigrants were examined and thirty three thousand, eight hundred and forty seven were debarred because of tracoma. So it would be zero point sixteen percent. Wow. Another quote, it was common to have two to five percent of
prospective immigrations rejected. Eighty five percent of those rejections were due to tracoma.
I wow.
I know you would think that, based on how seriously the US was taking tracoma in the context of like immigration stuff, that there would be almost no tracoma in the country. Right.
Oh, you'd think, right, I think right, it's logical.
Oh, of course that's not true, though. The first detailed look at tracoma in the US came out around nineteen eleven. That year, a physician from Lexington, Kentucky, released a report that showed just how prevalent tracoma was, especially in eastern Kentucky and across rural Appalachia through to Kansas and Oklahoma. Rates of tracoma in these regions were comparable to or greater, much greater than many of the countries from which people
were emigrating. For instance, Native Americans were among those most impacted, with an average prevalence rate of twenty three percent, but it gets worse. In some Native American boarding schools in Oklahoma, that number would shoot up to a horrific ninety two percent.
Ninety two percent, yeah, oh my. This report did kind of awaken public health officials to the tremendous issue that tracoma already posed in parts of the US, and so they created tricoma hospitals and state specific control programs, and over the early nineteen hundreds, especially the nineteen thirties and the nineteen forties, trachoma did sharply decline in the US and in many countries in Europe where it had been prevalent essentially countries that were like higher income countries, And
I think it's not the easiest thing to tease out exactly why this decline occurred and how much these treatment centers contributed versus infrastructural improvements in things like sanitation and clean water that made it possible for people to regularly practice like these hygiene practices that would help them keep
their face clean, et cetera. Based on the timing of the declines, it's possible that antibiotics like sulfonamides played a role, but if they did, I have to feel like it was a fairly minor one, since the decrease seemed to happen in many places long before the widespread introduction of these antibiotics.
Which is really interesting in the context of current events.
It certainly is. Yeah, yeah, this is such a good illustration of how disease prevalence can be reduced through changes in infrastructure rather than just treatment alone. And I think it also shows that treatment alone is never going to be sufficient.
Nail head.
But as usual, this decline in tracoma was not universal, nor did it happen evenly across the landscape. In the US, for example, tracoma persisted in many Native American communities through the nineteen eighties, and in Australia it continues to be a problem in indigenous communities, and there are many regions around the world that still have high rates of tracoma,
which I know you'll talk more about, Aaron. Wasn't really until the mid nineteen hundreds that international organizations like the WHO started tracoma control programs for some low and middle income countries, and they set an elimination goal only in the mid nineteen nineties, which, honestly, it really surprised me after reading about this history, where I was like, wait, it's preventable, it's treatable, and it also has an absolutely enormous impact on quality of life.
Yep.
So I've almost gotten all the way to the end of the tracoma history part without even talking about the causative agent really and like how it was identified and who discovered it and so on. And one of the reasons for that is, like I said earlier, knowing exactly what caused this condition didn't seem to be necessary to stop the cycle of transmission and reduce prevalence in some places.
But what the identification of chlamydia trachomatists did was allow people to distinguish trachoma from other acute types of eye inflammation, enabled them to see which treatments might work best, and also let them look for other ways that this bacterium could infect humans, such as genitally genitals. So let's go back in time to one chlamydia trichomitis was first identified. The late decades of the eighteen hundreds could be considered
the heyday of germ theory. People were identifying bacterial or parasitic causes of diseases left and right. I mean really, like, can you imagine the dissertation would be like I looked in this person's boogers and I found this boom give me a science or nature of paper. I don't think they existed back then, but in theory, in theory, yeah. And so when a disease existed that a bacterium or parasite wasn't easily like or readily identified, it wasn't like, oh,
this must not be infectious. It was often assumed that it was a transmissible, filterable agent aka a virus, and trichoma fell into this category at first, of course, until nineteen o seven, when Halberstetter and von Prowseek used a special stain to visualize the bacteria in trichoma, but they didn't realize at that time that it was bacteria they
were seeing. They thought it was intracellular protozoa that appeared to cloak the nucleus of the cells they infected, which gave rise to the name climytozoa, after the Greek word for cloak.
Oh, that's fun.
Yeah, And of course it was later changed to chlamydia once people realized that they were not protozoa but bacteria. So, now that people had found what caused trachoma, did that mean that they would also be able to link it to the genital infection? Not exactly. If you think back to our Gonerhea episode, I think I mentioned how I didn't check my notes prior to the identification of the
Gonerhea bacteria. It's hard to tease a part which historical descriptions of genital infections are actually gonerrhea versus something else based on symptoms alone, and the identification of Nicia Gonereea allowed people to finally say this is definitely gonerreea, which also meant that they could say, well, I don't know what this is, but it's certainly not gonereea, and we can't treat it with the same things as we do gonoreea. And so this is how non gonococcal urethritis or non
specific urethritis became a diagnosis. It was this diagnosis of exclusion that makes sense. People did look for the cause of non ganacoccal urethritis, which I'm just gonna call n GU moving forward, But one problem was that it wasn't just one thing causing it. Right later research has shown that it can be caused by chamydia trichomitus, mycoplasma, genitalium trichomonas, among others, but people didn't know it was like all
of these things could cause it at that time. Yeah, So if you're a researcher, let's say you're like digging in some secretions and trying to find out what the cause of this infection was, and you're like, I think I found it. I got it, And then you go over to a friend, take your little horse and buggy, go over to your friend and you say, I think I found it. Do you see it in your secretions? And he goes, no, I don't, this is something totally different. So you didn't get the right one right.
You just feel really bad about yourself, feel like every my experiment failed right.
And you're like, I'm leaving academia, and I'm not. I can't do this anymore. I quit.
I'm going to make a podcast. Sorry, that was funny.
That was really good. But researchers did try to minimize this confusion about what caused NGU by seeing if they could distinguish among different types of NGU. Okay, how long was the incubation period, what were the symptom, how long did they last? Things like that. And one of these people who was trying to characterize ngu's was named Ludwig.
And I don't know how you pronounce this name, but I'm very excited about it because it is spelled wae lscch, which is very close to Welsh, and so I'm just going to call him Ludwig Welsh. And he described a quote rare form of NGU that had an incubation period of ten to fourteen days. The course of the disease was mild but long, and it was difficult to treat
using the antibiotics of the day. Additional work also showed that the mucous membrane in cases of Welsh erythritis, as it would be called, was reddened with soft multiple infiltrates quote like the nodules in tracoma. Interesting, people had made a possible connection with the tracoma agent and genital infections before this. One gruesome experiment even involved taking material from people's genitals who had NGU and then applying that to the eyes of monkeys, and sure enough they developed an
eye infection. There's definitely no io Cook approval on that one, for sure, no. But it seems like the tracoma agent was just a tricky bug to work with, and it was hard to know what it was or what it wasn't responsible for, including trachoma because there was still some debate about that, and also there was no ability at
the time to culture it. And even with well scheerithritis, sometimes people saw chlamydia in the scrapings of infected tissue under the scope and other times they didn't, but the link seemed strong enough for at least one researcher to suggest that this well scheerythritis was quote a genital tricoma.
The debate continued for decades, but in the nineteen thirties, American ophthalmologist Philip Thiguson drew a link between neonatal ocular infection and being exposed to genital infection during birth, and later that decade he also showed that trachoma could be treated with sulfonamides, which was actually a pretty huge, pretty
huge deal at the time. After the introduction of penicillin in the nineteen forties, which could be used to treat gonorrhea but not ngus, interest in NGU and the possible link between trachoma and genital infection increased even more. But the real turning point for both trachoma and chlamydia would come about in nineteen fifty seven. Earlier, when I said that scientists thought that trachoma could be caused by a virus,
they weren't actually that far off right. Chlamydia trichomatis acts like a virus in many ways, and this similarity to viruses, where they have to basically hijack a host sales machinery to replicate it kept researchers from being able to culture them for fifty years after their initial identification.
Wow fifty years, Yeah, it's a long time, and that made it.
Really difficult to fully characterize the bacterium, see its life cycles, and see like where it was involved. In nineteen fifty seven, Tang fey Fan, along with a research team, was able to culture the bacteria in a chick embryo. This was a huge breakthrough because it allowed people to culture large amounts of these bacteria, which led to careful characterization of its infection cycle, diagnostic tests, exploration into vaccines, antibiotic sensitivity testing,
and so on. And two years after chlamydia could finally be cultured, it was isolated after delivery from both the cervix as well as the eyes of the infant who had inclusion conjunctivitis. People were finding more and more chlamydia in genital infections, and by nineteen sixty five, the number of cases of NGU, many of which were chlamydia, possibly most of which finally surpassed that of gonorrhea in the US, really illustrating how important it was to be able to
distinguish among these NGU infections right. It was no longer enough to just say there ngu, that's NGU. Finally, chlamydia as an STI became a clinical entity in the nineteen seventies w I no and even then it would be another ten or more years before it became a notifiable
disease in some places. In the nineteen eighties is when people started to discuss the possible ties between chlamydia and public inflammatory disease and infertility, and it seems like around the time of that research is when chlamydia began to be labeled as a disease of promiscuity, especially promiscuous women, which is really no different from how women were viewed historically as the sources of STIs, but not people who needed to be treated themselves, right.
Which is I can't even tell you how frustrating, especially in the context of chlamydia today. But anyways, that's my personal high horse and I'll step off.
No, it is really frustrating, especially when you read these descriptions of treatment that we're not that old, right from the seventies to eighties, and the way that they describe treatment is that in order to reduce chlamydia in men, we should prescribe antibiotics in women. Oh and I guess it'll treat them too.
That's fascinating because I literally just read a paper that was like, what if we actually screen men, can we reduce the rates in women? Because we still aren't screening.
We still aren't screening, Are you serious?
Yeah? And people with a penis that is still not recomend for general spreading.
It's wow.
Yeah, And the link between infertility and chlamydia seemed to be used to push this like judgmental, moralistic narrative where infertility was the punishment for being promiscuous, the world was witnessing a silent but deadly epidemic of infertility. Oh god, things like that, and all during this cases of chlamydia did seem to be on the rise, although it was only routinely included in STI statistics in the US and Europe starting in nineteen ninety.
So I realized this was kind of just like a brief foray into these two different diseases with very distinct histories and social impacts. And I could have probably spent an episode on each of them had we known, had we known, But I think that what they both show us going back to kind of like the theme I feel like for this episode is how easy it can be for a diagnosis to become wrapped up in someone's identity and how important it is that we don't let
that happen. Yeah. So Aaron, I would love for you to tell me more about where we stand with chlamydia and trachoma today.
I can't wait to right after this break. When it comes to trachoma, this remains the most common infectious cause of blindness worldwide.
Yeah, it's it's really common.
It's really common. It's responsible for blindness or visual impairment in almost two million people, which is about one point four percent of all blindness worldwide, and globally, an estimated one hundred and thirty six million people in forty four countries across the globe live in tricoma endemic areas and are therefore at risk of infection, which is a lot of human beings. Yeah. Yeah, And like you kind of mentioned, Aaron, the World Health Organization, the World Health Assembly, has targets
for like global elimination, which sounds so great. But the initial target date was twenty TWENTYMWOMPOM, so the new target is twenty thirty.
How are we doing with that target?
By the way, well, I actually have some great news on that front, thanks for asking. As of March seventh, twenty twenty two, fourteen countries have newly reported achieving elimination goals. So I feel like that's something worth celebrating.
That's huge.
Yeah, that's very big. Unfortunately, the COVID pandemic put a very big damper on public health efforts. In twenty twenty, half as many people received corrective surgery to treat trachiasis and reduce the progression of visual impairment, and way less than half as many people as in twenty nineteen received antibiotic prophile axis or treatment. So that's a big bummer. But we're still at least seeing progress in a lot of places, so that's really good.
That's great.
Yeah, And like we kind of talked about before, the strategies to kind of treat this, I'll post the World Health organizations like information for people who want to read more.
But it is a very.
Multi tiered approach, which I think is important. Not only do they target inf structure to be able to increase access to clean water and sanitation, which is going to be able to reduce the spread of infection, it also includes antibiotic treatment in mass antibiotic campaigns, especially in hyper endemic areas, because this does tend to be a disease that in certain areas will be at really really high prevalence, and then in other areas will be at much lower prevalence,
so mass antibiotic campaigns and then also surgical correction to be able to reduce the progression of disease in people who already had it as children.
Where are some of these hyperendemic regions? Like, how is this distributed across the globe?
Great question? So across the globe, it's the most economically disadvantaged and rural areas of Africa, Central and South America, Asia, Australia, and the Middle East. So the kind of most economically disadvantaged, poorest, most rural regions that tend to be the most hyperendemic.
Gotcha.
In terms of the STI chlamydia, we are talking about the most common bacterial sexually transmitted infection. Yeah, the most common one. The most recent studies that I read estimated a global incidence of one hundred thirty one million new
cases every year. That's a lot of cases, a lot of humans, with an estimated global prevalence of around four percent or so three point eight to four point two of people with a cervix so a cervical infections and anywhere from just under three percent to about seven percent were the estimates that I saw of people with a penis.
Surprisingly to no one, we don't have as good of data on penile urethral infections because most countries do not universally screen people with a penis for infection the way that they do screen young adult people with a cervix universally, which is again something that I hope will change in the next coming years. And importantly, it does tend to be young adults age eighteen to twenty six tend to
have the highest prevalence. So overall it's probably close to three to four percent of the population adult population infected at any given time. Got that's a lot of humans. And in the US as of twenty nineteen, there were over one point eight million cases reported annually. And if you look just at the highest risk group that we screen that we have good data on, that is people age fifteen to twenty four with a cervix, the annual incidence is over three thousand, seven hundred cases per one
hundred thousand people. Okay, that is incredibly common.
It's very common.
So I feel like one of the things that I hope that these numbers really highlight and kind of going back to what you were talking about, Aaron, about how chlamydia infection has been used in the past to like have a lot of shame and stigma specifically associated with it. This is an incredibly common infection. It is not something that only a certain type of people can have, or only a certain type of people are going to be
at risk for. When we're talking about sexually transmitted bacterial infection as common as this, anyone having sexual contact of any kind is going to be at some risk of infection. People having multiple different kinds of sex or sex with multiple people, of course, are going to have a higher risk. But whether you're having any type of sex with one person or multiple people, things like using condoms can decrease
our risk getting tested, getting treated. Talking about this infection and making it less shameful so that we have an awareness about it is the way that we reduce this infection. Because it's not that it's inherently bad or shameful to get a sexually transmitted infection, but they can be really serious, and we have ways to reduce the risk and to be able to treat these infections. So I think that's really important.
Yeah, that was really well said. I agree with I agree with that.
Thanks, And speaking of prevention, what about vaccines Arin.
What about vaccines erin, Yeah, we don't have one yet yet.
I read a really interesting paper that was looking at all chlamydias and over the last seventy years there have been at least two hundred and twenty different vaccine trials, and in the last ten years alone, there's been an average of twelve vaccine studies per year on chlamydia, which is like one a month, so that's thrilling. Not all of these studies have been on our friend chlymydia trachomitis. A lot have also been on species affecting koalash that's
a spoiler. So far, still no vaccine, but of course lots of people doing fantastic research to get us closer.
Speaking of fantastic people doing research to get us closer to a chlamydia vaccine, uh huh. I am very excited for a next week's bonus episode when I get to chat with not one but two researchers working on chlamydia in domestic animals and wildlife, including Kowalas doctor Martina Yelochnik and doctor Sam Phillips, both from the University of the Sunshine Coast in Queensland, Australia will be joining me to talk about other chlamydia species of wildlife or veterinary health importance.
We'll be talking about how these infections have led to declines in certain animal populations, as well as the latest news regarding a chlamythia vaccine for koalas. So make sure you don't miss it, because it's going to be great.
I can't I really can't wait. That's chlamydia and trachoma.
Yeah, this was a very packed full episode. Yeah.
Yeah, that's a good way to say it.
Uh. Should we round it out with some sources?
We sure ought to.
I had a few, But what I really want to highlight R two one is a book called Trachoma by Hugh Taylor, and that is a fantastic overview of everything Tracoma. And then for chlamydia, there is a chapter by war Boys from twenty nineteen called Chlamydia A Disease without a History.
I read a lot of papers for this since there was so many different aspects of it, So I'm not gonna specifically shout out any in particular, but suffice to say, if you want more details on the specific immunology and cell biology, path of physiology of Clamydia trachomatis. I've got papers for you if you want more details on reactive arthritis, got a couple of papers for you. You want more on those seventy years of vaccine research? Oh, I got it.
More on tracoma.
It's there. Check out our website This podcast will Kill You dot com and you'll find a list of every single source from this episode and all of our episodes. There's like ninety something.
Yeah, there's ninety something. Thank you again so very much to the listener who sent in their first hand account for this episode. Again, we really appreciate your willingness to put yourself out there and be vulnerable.
Yeah, thank you. And thank you also to Bloodmobile for providing the music for this episode and all of our episodes.
And thank you to exactly Right Listen, follow and leave us a review on Amazon Music, Apple Podcasts, or wherever you get your podcasts and don't forget. You can listen to new episodes one week early on Amazon Music or early and ad free by subscribing to Wondery Plus in the Wondery app.
And thank you to you listeners. We really appreciate you listening, and we hope that you liked this episode.
We do, and a special thank you also to our wonderful generous patrons. We love you well. Until next time, wash your hands.
You filthy animals.
Oh buba buba bubo
Oh
